What are the preferred single-agent microtubule inhibitor regimens for the treatment of recurrent or metastatic breast cancer?

Updated: Apr 23, 2020
  • Author: Joseph A Sparano, MD; Chief Editor: John V Kiluk, MD, FACS  more...
  • Print
Answer

Answer

Regimens are as follows:


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!